Advertisement

Critical evaluation of the methodology used by Wilson-Davies et al., (2020) entitled Concerning the Optigene Direct LAMP assay, and it`s use in at-risk groups and hospital staff”

Published:February 08, 2021DOI:https://doi.org/10.1016/j.jinf.2021.01.012
      Dear Editor-in-Chief,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. https://www.gov.uk/government/publications/rapid-evaluation-of-optigene-rt-lamp-assay-direct-and-rna-formats/rapid-evaluation-of-optigene-rt-lamp-assay-direct-and-rna-formats 2020.

        • Fowler V.L.
        • Armson B.
        • Gonzales J.L.
        • et al.
        A highly effective reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection.
        J Infect. Nov 2020; 30 (S0163-4453(20)30731-3)
      2. https://www.theguardian.com/world/2020/nov/05/operation-moonshot-rapidcovid-test-missed-over-50-of-cases-in-pilot 2020.

        • Alexandersen S.
        • Chamings A.
        • Bhatta T.R.
        SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication.
        Nat Commun. 2020 Nov 27; 11 (PMID: 33247099; PMCID: PMC7695715): 6059https://doi.org/10.1038/s41467-020-19883-7
      3. Benrahma H., Diawara I., Smyej I., et al. Epidemiological description and analysis of RdRp, E and N genes dynamic by RT-PCR of SARS-CoV-2 in Moroccan population: experience of the National Reference Laboratory (LNR)-UM6SS. medRxiv; 2020. DOI:10.1101/2020.06.18.20135137.

        • Danzetta M.L.
        • Amato L.
        • Cito F.
        • Di Giuseppe A.
        • Morelli D.
        • Savini G.
        • Mercante M.T.
        • Lorusso A.
        • Portanti O.
        • Puglia I.
        • Monaco F.
        • Casaccia C.
        • Di Gennaro A.
        • Testa L.
        • Migliorati G.
        • D'Alterio N.
        • Calistri P
        SARS-CoV-2 RNA persistence in Naso-Pharyngeal Swabs.
        Microorganisms. 2020 Jul 26; 8 (PMID: 32722621; PMCID: PMC7466010.): 1124https://doi.org/10.3390/microorganisms8081124
      4. Loying P., Sarma V., Hazarika S.C., Kataki M., Raja D., Medhi D., Dutta R., Chena A., Daimary D., Choudhury A., Saikia L. Dynamics of ORF1ab and N gene among hospitalized COVID-19 positive 2 cohorts: a hospital based retrospective study. 2020 Nov. https://www.medrxiv.org/content/10.1101/2020.11.22.20236240v1.full.pdf.

        • Saeed K.
        • Pelosi E.
        • Mahobia N.
        • et al.
        Investigations, actions and learning from an outbreak of SARS-CoV-2 infection among healthcare workers in the United Kingdom.
        J Infect Prev. December 2020; https://doi.org/10.1177/1757177420976798
        • Kim D.
        • Lee J.Y.
        • Yang J.S.
        • Kim J.W.
        • Kim V.N.
        • Chang H.
        The architecture of SARS-CoV-2 transcriptome.
        Cell. 2020 May 14; 181 (e10. doi:10.1016/j.cell.2020.04.011. Epub 2020 Apr 23. PMID: 32330414; PMCID: PMC7179501): 914-921
        • Borghi E.
        • Massa V.
        • Carmagnola D.
        • et al.
        Saliva sampling for chasing SARS-CoV-2: a Game-changing strategy.
        Pharmacol Res. 2020; https://doi.org/10.1016/j.phrs.2020.105380
        • Yokota I.
        • Shane P.Y.
        • Okada K.
        • et al.
        Mass screening of asymptomatic persons for SARS-CoV-2 using saliva.
        Clin Inf Dis. 2020; https://doi.org/10.1093/cid/ciaa1388
        • Hanson K.E.
        • Barker A.P.
        • Hillyard D.R.
        • Gilmore N.
        • Barrett J.W.
        • Orlandi R.R.
        • Shakir S.M.
        Self-collected anterior nasal and saliva specimens versus health care worker-collected nasopharyngeal swabs for the molecular detection of SARS-CoV-2.
        J Clin Microbiol. 2020; 58 (e01824–e01820)https://doi.org/10.1128/JCM.01824-20
      5. Silva J., Lucas C., Sundaram M., Israelow B., Wong P., Klein J., Tokuyama M., Lu P., Venkataraman A., Liu F., Mao T., Oh J.E., Park A., Casanovas-Massana A., Vogels C.B.F., Muenker C.M., Zell J., Fournier J.B., Campbell M., Chiorazzi M., Fuentes E.R., Petrone M., Kalinich C.C., Ott I.M., Watkins A., Moore A.J., Nakahata M.I., Yale IMPACT Team, Grubaugh N.D., Farhadian S., Dela Cruz C., Ko A., Schulz W.L., Ring A.M., Ma S., Omer S., Wyllie A.L., Iwasaki A. 2021. Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality. medRxiv 2021.01.04.21249236; doi:https://doi.org/10.1101/2021.01.04.21249236.

      6. https://www.gov.uk/government/publications/how-tests-and-testing-kits-for-coronavirus-covid-19-work/target-product-profile-laboratory-based-sars-cov-2-viral-detection-tests 2020.

      Linked Article

      • Home-based SARS-CoV-2 lateral flow antigen testing in hospital workers
        Journal of InfectionVol. 82Issue 2
        • Preview
          We read with interest the recent paper from Fowler et al. on the use of a reverse transcriptase loop mediated isothermal amplification (RT-LAMP) assay for rapid detection of SARS-CoV-2 infection1 and the subsequent recommendation of its suitability for asymptomatic staff testing.2 Lateral flow device (LFD) antigen tests have also been proposed as rapid point-of-care diagnostics for SARS-CoV-2 infection and have the advantage over the RT-LAMP assay in that they can be self-delivered by healthcare workers at home with immediate results.
        • Full-Text
        • PDF
      • Concerning the OptiGene Direct LAMP assay, and it’s use in at-risk groups and hospital staff
        Journal of InfectionVol. 82Issue 2
        • Preview
          The COVID-19 pandemic has triggered an unprecedented demand for diagnostic tests. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is highly contagious in the pre-symptomatic period, when the viral load is high. In the effort to reduce transmission, for the first time in infection diagnostics history, testing is being aimed not only at symptomatic, but also at asymptomatic individuals, both in the health care setting and in the community.
        • Full-Text
        • PDF